Renaissance Technologies’s Acorda Therapeutics ACOR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
|
|||||
2024
Q1 | $618K | Buy |
|
|||||
2023
Q4 | $691K | Sell |
|
|||||
2023
Q3 | $690K | Buy |
|
|||||
2023
Q2 | $593K | Buy |
|
|||||
2023
Q1 | $519K | Buy |
|
|||||
2022
Q4 | $666K | Buy |
|
|||||
2022
Q3 | $256K | Sell |
|
|||||
2022
Q2 | $420K | Buy |
|
|||||
2022
Q1 | $1.14M | Sell |
|
|||||
2021
Q4 | $1.71M | Sell |
|
|||||
2021
Q3 | $3.33M | Buy |
|
|||||
2021
Q2 | $3.41M | Sell |
|
|||||
2021
Q1 | $3.97M | Buy |
|
|||||
2020
Q4 | $2.82M | Buy |
|
|||||
2020
Q3 | $1.98M | Sell |
|
|||||
2020
Q2 | $2.83M | Buy |
|
|||||
2020
Q1 | $3.56M | Sell |
|
|||||
2019
Q4 | $7.87M | Sell |
|
|||||
2019
Q3 | $11.6M | Sell |
|
|||||
2019
Q2 | $35M | Buy |
|
|||||
2019
Q1 | $53.3M | Buy |
|
|||||
2018
Q4 | $34.1M | Buy |
|
|||||
2018
Q3 | $25.1M | Buy |
|
|||||
2018
Q2 | $19.5M | Buy |
|
|||||
2018
Q1 | $4.91M | Buy |
|
|||||
2017
Q1 | – | Sell |
|
|||||
2016
Q4 | $7.25M | Sell |
|
|||||
2016
Q3 | $9.53M | Buy |
|
|||||
2016
Q2 | $5.94M | Buy |
|
|||||
2016
Q1 | $1.63M | Sell |
|
|||||
2015
Q4 | $7.53M | Buy |
|
|||||
2015
Q3 | – | Sell |
|
|||||
2015
Q2 | $9.48M | Sell |
|
|||||
2015
Q1 | $10.6M | Buy |
|
|||||
2014
Q4 | $2.21M | Sell |
|
|||||
2014
Q3 | $3.32M | Buy |
|
|||||
2014
Q2 | $1.4M | Sell |
|
|||||
2014
Q1 | $8.25M | Sell |
|
|||||
2013
Q4 | $7.31M | Buy |
|